Clinical Trials Logo

Vulvar Cancer clinical trials

View clinical trials related to Vulvar Cancer.

Filter by:

NCT ID: NCT00275353 Completed - Cervical Cancer Clinical Trials

Effectiveness of an Individualized Symptom Education Program (ISEP)

Start date: July 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine whether an Individualized Symptom Education Program (ISEP) is helpful to women to manage their symptoms when they are receiving radiation therapy for gynecological cancer. It is expected that women who participate in the ISEP program will be better able to manage their symptoms and exprience less distress than women who receive usual care.

NCT ID: NCT00033605 Completed - Prostate Cancer Clinical Trials

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Start date: April 2002
Phase: Phase 3
Study type: Interventional

RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who are undergoing radiation therapy to the pelvis. It is not yet known whether octreotide is effective for diarrhea. PURPOSE: Randomized phase III trial to determine the effectiveness of octreotide in preventing diarrhea in patients who are undergoing radiation therapy to the pelvis.

NCT ID: NCT00028951 Completed - Lymphedema Clinical Trials

Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva

Start date: January 2003
Phase: Phase 3
Study type: Interventional

RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial to determine the effectiveness of fibrin sealant in reducing lymphedema following surgical removal of lymph nodes in patients who have cancer of the vulva.

NCT ID: NCT00019110 Completed - Clinical trials for Head and Neck Cancer

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Start date: November 1995
Phase: Phase 1
Study type: Interventional

RATIONALE: Vaccines made from certain human papillomaviruses may be able to help the body to kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of human papillomavirus vaccine therapy in treating patients who have advanced or recurrent cancer of the cervix, vagina, penis, anus, esophagus, or head and neck.

NCT ID: NCT00014599 Completed - Vulvar Cancer Clinical Trials

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Start date: February 2001
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients who have locally advanced, metastatic, or recurrent cancer of the vulva.

NCT ID: NCT00003325 Completed - Vulvar Cancer Clinical Trials

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Start date: December 1999
Phase: Phase 3
Study type: Interventional

RATIONALE: Lymphatic mapping may improve the ability to detect cancer of the vulva. PURPOSE: This phase III trial is studying how well lymphatic mapping works in treating patients with stage I or stage II cancer of the vulva.